RYARX | RYUCX | RYARX / RYUCX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 21 years | 24 years | - |
Gain YTD | -15.431 | -15.987 | 97% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 2500 | 2500 | 100% |
Min. Initial Investment IRA | 1000 | 1000 | 100% |
Net Assets | 33.4M | 33.4M | 100% |
Annual Yield % from dividends | 3.32 | 3.88 | 86% |
Returns for 1 year | -19.46 | -20.07 | 97% |
Returns for 3 years | -17.52 | -19.34 | 91% |
Returns for 5 years | -53.79 | -55.48 | 97% |
Returns for 10 years | -73.94 | -75.83 | 98% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VILSX | 41.70 | 0.24 | +0.58% |
Value Line Select Growth Institutional | |||
SCMGX | 32.87 | 0.14 | +0.43% |
Sands Capital Global Growth Inst | |||
RCGHX | 17.05 | -0.06 | -0.35% |
Virtus KAR Health Sciences C | |||
MGPSX | 81.93 | -0.50 | -0.61% |
ProFunds Mid Cap Growth Svc | |||
JCNNX | 32.27 | -0.30 | -0.92% |
Janus Henderson Contrarian N |